Immix Biopharma (IMMX) Minority Interest (2023 - 2024)
Quarterly results put Minority Interest at -$283282.0 for Q1 2024, down 775.46% from a year ago — trailing twelve months through Mar 2024 was -$283282.0 (down 775.46% YoY), and the annual figure for FY2023 was -$201737.0, changed.
Immix Biopharma has reported Minority Interest over the past 2 years, most recently at -$283282.0 for Q1 2024.
- Minority Interest reached -$283282.0 in Q1 2024 per IMMX's latest filing, down from -$201737.0 in the prior quarter.
- Across five years, Minority Interest topped out at -$32358.0 in Q1 2023 and bottomed at -$283282.0 in Q1 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Immix Biopharma | 476.17 Mn | 476.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -283,282.00 |
| Dec 31, 2023 | -201,737.00 |
| Sep 30, 2023 | -124,667.00 |
| Jun 30, 2023 | -56,770.00 |
| Mar 31, 2023 | -32,358.00 |